Price: $9.67
· 1 day: +1.04% · 5 days: +4.09% · 1 month: +4.54% · YTD: -52.32%
As of 2026-11-03 21:01 UTC.
52-week range: $8.94 – $28.23 (currently at 4% of the range).
XPEV is in a downtrend, momentum firm. $10 is the level overhead; $9.04 the first support below.
3 of 6 technical checks lean bearish.
| Trend | Downtrend · below 50-day & below 200-day |
|---|---|
| Momentum | RSI 53.56 · bearish · MACD bullish |
| Trend strength | ADX 21.5 · developing |
| Location | -4.0% vs 50-day MA |
| 52-week range | -66% from high · +7% from low |
| Volatility | ATR 0.37 · ~3.8%/day |
| Level | Type | Distance |
|---|---|---|
| $10.0 (resistance) | round | 3.41% |
| $10.07 (resistance) | sma 50 | 4.14% |
| $10.14 (resistance) | swing zone | 4.86% |
| $9.04 (support) | 52w low | -6.51% |
| $9.0 (support) | round | -6.93% |
| $8.0 (support) | round | -17.27% |
| RSI (14) | 53.56 | MACD | -0.1986 |
|---|---|---|---|
| ADX (14) | 21.5 | ATR (14) | 0.37 |
| 50-day average | $10.07 | 200-day average | $14.36 |
Next earnings: 2026-11-16. XPEV earnings date, time and past reactions.
Report of 2026-10-28.
XPeng (XPEV) trades at $9.29, just 2.4% above its 52-week low of $9.07, after losing 6.3% in five days while the S&P 500 and the consumer discretionary sector (XLY) went nowhere. The balance of evidence leans negative for the next two to six weeks, with high conviction: the daily trend runs with the weekly downtrend, and the stock trails both benchmarks. The downside math, however, is thin.
There is no company news in the feed for this stretch: no delivery print, no guidance change, no analyst action. So the drop cannot be pinned on an event, and that matters. A stock that falls without a headline is being repriced by holders and sellers, not by a single piece of information. The pattern fits: the last peak was a close of $10.29 on September 23, 2026, and the shares have since slipped 9.7% from it.
The attribution is clean. Over five days XPEV fell 6.3%, SPY gained 0.08% and XLY slipped 0.04%. Stripped of the sector, the stock still lost 6.2%, so essentially all of the move belongs to XPEV itself. The longer window says the same. Over one month the stock is down 8.2% while XLY is up 4.4%. Over 50 days it trails the S&P 500 by 10.2% and XLY by 11.6%. Today's 1.9% bounce, on volume 23.4% below the 20-day average, looks more like a pause than a change of mind.
The debate is hard to document here because no articles on it are in the feed. What the numbers show is a split between the tape and the analysts. All 25 analysts together rate the stock a buy, with a mean price target of $17.99, a range of $10.01 to $25.39, and the mean sitting 48.4% above the current price. Even the lowest target is above where the stock trades. The price is saying the opposite: the stock is down 43.9% over six months and 54.2% year to date, and it sits below both the 50-day average at $10.32 and the 200-day at $14.65. Targets of that kind tend to follow price down rather than lead it, and nothing in the evidence shows the gap closing yet.
On the long term, the thesis is broken for now. Price is below its 40-week average, the stock is 66.9% under its 52-week high of $28.07, and the 200-day average is far above the price. This is a late-stage decline, not an early one: the stock has been pushed to the bottom of its yearly range and has not yet shown that it can build a base there. The market value is about $8.9 billion, a long way from where the stock stood a year ago.
For the next two to six weeks the evidence leans negative, and conviction is high, at 3 of 4 points. The daily trend runs with the weekly downtrend, so short-term moves and the larger direction point the same way. The stock lags the S&P 500 by 10.2% and XLY by 11.6% over 50 days, which means money has been leaving XPEV even as the broader market and the sector held up. One of the four checks does not line up, which is why conviction stops short of the maximum.
The strongest case against this reading is that the stock is already close to its floor. The 14-day RSI is 46, which is not oversold, so the selling has not been disorderly, but the shares are within 2.4% of the yearly low and a recent peak only 9.7% above. A rebound through $10.00 and the 50-day average at $10.32 would not be unusual from here. Volume has also faded, and every analyst target is above the price. None of this tips the balance, because a bounce needs a weekly close above $10.32 to count, and there is no sign of one yet. It is part of why conviction is not at its top.
The structure stays negative below $10.00, a round number where sellers have shown up on earlier rallies. Just above it sit a swing zone at $10.14 and the 50-day average at $10.32, and the weekly downtrend would end only with a weekly close above $10.32. Higher resistance sits at $11.00 and $12.33. Below the market, the support is the 52-week low at $9.07, then $9.00, then $8.00.
The downside breakout level is a daily close below $9.07. From there the first target is $9.00, only a few cents away, and the second is $8.00. The stop is $10.10, which is $10.00 plus a quarter of the 14-day ATR of $0.38, and it is the level where the breakdown idea would be wrong. Against that stop the first target gives 0.1 to 1 and the second gives 1.0 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk, and it would take a much lower target or a much tighter stop for that to change.
A weekly close above $10.32, the 50-day average, would be the first sign that buyers are back and that the weekly downtrend is losing hold. The non-price fact that would most likely do it is an earnings report showing demand and margins stabilizing, because with no news in the feed, the stock has no new information pulling it higher. Without that, a bounce toward $10.00 would more likely meet the same sellers as before.
Interactive XPEV chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs